Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• SARS-CoV-2 employs mechanisms to evade host interferon (IFN) responses.
• The viral accessory protein ORF6 is a potent antagonist of IFN production and signaling.
• ORF6's role in IFN antagonism is linked to its localization at the nuclear envelope, inhibiting transcription factor nuclear import.

Purpose of the Study:

• To experimentally investigate the relationship between SARS-CoV-2 ORF6 protein localization and its function in antagonizing IFN signaling.
• To identify structural determinants of ORF6 localization and assess the impact of mislocalization on IFN antagonism.
• To explore the membrane association of ORF6 and its implications for viral replication.

Main Methods:

• Extensive mutagenesis of the ORF6 protein to define localization determinants.
• Expression of ORF6 variants with altered localization.
• Use of a peptide mimicking the ORF6-Nup98 interaction domain.
• Pharmacologic and mutational approaches to investigate membrane association.

Main Results:

• Mis-localized ORF6 variants retained potent inhibition of nuclear trafficking and IFN signaling.
• A peptide mimicking the ORF6-Nup98 interaction domain effectively blocked nuclear trafficking.
• Evidence suggests ORF6 is a peripheral, not transmembrane, membrane protein.
• ORF6 localization and IFN antagonism were found to be independent activities.

Conclusions:

• SARS-CoV-2 ORF6 protein's ability to inhibit IFN signaling is independent of its specific localization.
• ORF6's peripheral membrane association suggests potential roles beyond nuclear transport inhibition.
• These findings open possibilities for additional ORF6 functions in viral replication within membrane networks.